Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Zeitlin

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|May 4, 2022
Special focus issue: passive immunizationLarry Zeitlin, Richard A Cone
Herpes : the Journal of the IHMF|March 28, 2002
Microbicides for preventing transmission of genital herpesLarry Zeitlin, Kevin J Whaley
Vaccine|March 1, 2005
Preventing transmission: plant-derived microbicides and mucosal vaccines for reproductive healthKevin J Whaley, Larry Zeitlin
Human Vaccines & Immunotherapeutics|July 14, 2021
Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturingKevin J Whaley, Larry Zeitlin
Antiviral Research|November 6, 2013
Antibody-based concepts for multipurpose prevention technologiesKevin J Whaley, Larry Zeitlin
Human Vaccines|March 2, 2011
Emerging antibody products and Nicotiana manufacturingKevin J Whaley, Andrew Hiatt, Larry Zeitlin
Biotechnology & Genetic Engineering Reviews|January 11, 2003
Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfacesLarry Zeitlin, Carrie Palmer, Kevin J Whaley
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2009
Second-generation HIV microbicides: continued development of griffithsinLarry Zeitlin, Michael Pauly, Kevin J Whaley
Clinical & Developmental Immunology|July 11, 2013
Multiantibody strategies for HIVAndrew Hiatt, Larry Zeitlin, Kevin J Whaley
Microbiology Spectrum|June 18, 2015
Plant-Derived Monoclonal Antibodies for Prevention and Treatment of Infectious DiseaseAndrew Hiatt, Kevin J Whaley, Larry Zeitlin
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|May 4, 2022
Special focus issue: passive immunizationLarry Zeitlin, Richard A Cone
Herpes : the Journal of the IHMF|March 28, 2002
Microbicides for preventing transmission of genital herpesLarry Zeitlin, Kevin J Whaley
Vaccine|March 1, 2005
Preventing transmission: plant-derived microbicides and mucosal vaccines for reproductive healthKevin J Whaley, Larry Zeitlin
Human Vaccines & Immunotherapeutics|July 14, 2021
Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturingKevin J Whaley, Larry Zeitlin
Antiviral Research|November 6, 2013
Antibody-based concepts for multipurpose prevention technologiesKevin J Whaley, Larry Zeitlin
Human Vaccines|March 2, 2011
Emerging antibody products and Nicotiana manufacturingKevin J Whaley, Andrew Hiatt, Larry Zeitlin
Biotechnology & Genetic Engineering Reviews|January 11, 2003
Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfacesLarry Zeitlin, Carrie Palmer, Kevin J Whaley
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2009
Second-generation HIV microbicides: continued development of griffithsinLarry Zeitlin, Michael Pauly, Kevin J Whaley
Clinical & Developmental Immunology|July 11, 2013
Multiantibody strategies for HIVAndrew Hiatt, Larry Zeitlin, Kevin J Whaley
Microbiology Spectrum|June 18, 2015
Plant-Derived Monoclonal Antibodies for Prevention and Treatment of Infectious DiseaseAndrew Hiatt, Kevin J Whaley, Larry Zeitlin
Pageof 10